Literature DB >> 33706238

HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes.

Mehdi A Benkahla1, Somayeh Sabouri1, William B Kiosses1, Sakthi Rajendran1, Estefania Quesada-Masachs1, Matthias G von Herrath2.   

Abstract

Human leukocyte antigens of class-I (HLA-I) molecules are hyper-expressed in insulin-containing islets (ICI) of type 1 diabetic (T1D) donors. This study investigated the HLA-I expression in autoantibody positive (AAB+) donors and defined its intra-islet and intracellular localization as well as proximity to infiltrating CD8 T cells with high-resolution confocal microscopy. We found HLA-I hyper-expression had already occurred prior to clinical diagnosis of T1D in islets of AAB+ donors. Interestingly, throughout all stages of disease, HLA-I was mostly expressed by alpha cells. Hyper-expression in AAB+ and T1D donors was associated with intra-cellular accumulation in the Golgi. Proximity analysis showed a moderate but significant correlation between HLA-I and infiltrating CD8 T cells only in ICI of T1D donors, but not in AAB+ donors. These observations not only demonstrate a very early, islet-intrinsic immune-independent increase of HLA-I during diabetes pathogenesis, but also point towards a role for alpha cells in T1D.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alpha cells; Beta cells; HLA class I; Type 1 diabetes; nPOD

Mesh:

Substances:

Year:  2021        PMID: 33706238      PMCID: PMC8044030          DOI: 10.1016/j.jaut.2021.102628

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  20 in total

1.  Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient.

Authors:  Jeremy Adler; Ingela Parmryd
Journal:  Cytometry A       Date:  2010-08       Impact factor: 4.355

2.  The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.

Authors:  Jeffrey P Krischer; Kristian F Lynch; Desmond A Schatz; Jorma Ilonen; Åke Lernmark; William A Hagopian; Marian J Rewers; Jin-Xiong She; Olli G Simell; Jorma Toppari; Anette-G Ziegler; Beena Akolkar; Ezio Bonifacio
Journal:  Diabetologia       Date:  2015-02-10       Impact factor: 10.122

Review 3.  ER Stress and β-Cell Pathogenesis of Type 1 and Type 2 Diabetes and Islet Transplantation.

Authors:  Hitomi Usui Kataoka; Hirofumi Noguchi
Journal:  Cell Med       Date:  2013-05-14

Review 4.  MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.

Authors:  Patrizia Leone; Eui-Cheol Shin; Federico Perosa; Angelo Vacca; Franco Dammacco; Vito Racanelli
Journal:  J Natl Cancer Inst       Date:  2013-07-12       Impact factor: 13.506

5.  Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes.

Authors:  Lars Krogvold; Bjørn Edwin; Trond Buanes; Gun Frisk; Oskar Skog; Mahesh Anagandula; Olle Korsgren; Dag Undlien; Morten C Eike; Sarah J Richardson; Pia Leete; Noel G Morgan; Sami Oikarinen; Maarit Oikarinen; Jutta E Laiho; Heikki Hyöty; Johnny Ludvigsson; Kristian F Hanssen; Knut Dahl-Jørgensen
Journal:  Diabetes       Date:  2014-11-24       Impact factor: 9.461

6.  Beta cell MHC class I is a late requirement for diabetes.

Authors:  Emma E Hamilton-Williams; Stephanie E Palmer; Brett Charlton; Robyn M Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-15       Impact factor: 11.205

Review 7.  T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review.

Authors:  Iria Gomez-Tourino; Sefina Arif; Martin Eichmann; Mark Peakman
Journal:  J Autoimmun       Date:  2015-09-03       Impact factor: 7.094

8.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

Authors:  Anette G Ziegler; Marian Rewers; Olli Simell; Tuula Simell; Johanna Lempainen; Andrea Steck; Christiane Winkler; Jorma Ilonen; Riitta Veijola; Mikael Knip; Ezio Bonifacio; George S Eisenbarth
Journal:  JAMA       Date:  2013-06-19       Impact factor: 56.272

9.  α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes.

Authors:  Marcela Brissova; Rachana Haliyur; Diane Saunders; Shristi Shrestha; Chunhua Dai; David M Blodgett; Rita Bottino; Martha Campbell-Thompson; Radhika Aramandla; Gregory Poffenberger; Jill Lindner; Fong Cheng Pan; Matthias G von Herrath; Dale L Greiner; Leonard D Shultz; May Sanyoura; Louis H Philipson; Mark Atkinson; David M Harlan; Shawn E Levy; Nripesh Prasad; Roland Stein; Alvin C Powers
Journal:  Cell Rep       Date:  2018-03-06       Impact factor: 9.423

10.  Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes.

Authors:  Sarah J Richardson; Teresa Rodriguez-Calvo; Ivan C Gerling; Clayton E Mathews; John S Kaddis; Mark A Russell; Marie Zeissler; Pia Leete; Lars Krogvold; Knut Dahl-Jørgensen; Matthias von Herrath; Alberto Pugliese; Mark A Atkinson; Noel G Morgan
Journal:  Diabetologia       Date:  2016-08-09       Impact factor: 10.122

View more
  3 in total

1.  Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes.

Authors:  Estefania Quesada-Masachs; Samuel Zilberman; Sakthi Rajendran; Tiffany Chu; Sara McArdle; William B Kiosses; Jae-Hyun M Lee; Burcak Yesildag; Mehdi A Benkahla; Agnieszka Pawlowska; Madeleine Graef; Susanne Pfeiffer; Zbigniew Mikulski; Matthias von Herrath
Journal:  Diabetologia       Date:  2021-12-21       Impact factor: 10.460

Review 2.  Pathogenesis of Type 1 Diabetes: Established Facts and New Insights.

Authors:  Ana Zajec; Katarina Trebušak Podkrajšek; Tine Tesovnik; Robert Šket; Barbara Čugalj Kern; Barbara Jenko Bizjan; Darja Šmigoc Schweiger; Tadej Battelino; Jernej Kovač
Journal:  Genes (Basel)       Date:  2022-04-16       Impact factor: 4.141

Review 3.  Making Insulin and Staying Out of Autoimmune Trouble: The Beta-Cell Conundrum.

Authors:  Alexia Carré; Roberto Mallone
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.